Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FIZZ | CCEP |
|---|---|---|
| Price | $29.84 | $101.47 |
| Change today | ▼ 1.58% | ▲ 0.41% |
| Market cap | $2.79B | $44.47B |
| Return, 3 months | +1.6% | -4.7% |
| Return, year to date | +3.5% | +13.1% |
| Return, 1 year | -10.7% | +18.9% |
| P/E (TTM) | 16.0 | 20.4 |
| P/B | 7.6 | 4.8 |
| P/E percentile vs own 5y | 2nd | 52nd |
| Dividend yield | – | 2.33% |
| Revenue growth (YoY, latest qtr) | – | +5.0% |
| Net profit growth (YoY) | – | +319.7% |
| Gross margin | – | 35.6% |
| Operating margin | – | 13.5% |
| Net margin | – | 9.3% |
| Return on equity | – | 24.5% |
| Analyst target vs. price | +3.9% | +11.1% |
| Analyst buy share | 0% | 78% |
| RSI (14) | 41 | 44 |
| 30-day volatility | 25.4% | 22.1% |
| Max drawdown, 1 year | -17.8% | -18.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
